Stockscreener 앱 받기
2.86
0.87%
-0.02
전일 마감가:
$2.88
열려 있는:
$2.9
하루 거래량:
1.19M
Relative Volume:
0.83
시가총액:
$434.33M
수익:
$181.41M
순이익/손실:
$-59.56M
주가수익비율:
-5.50
EPS:
-0.52
순현금흐름:
$-38.83M
1주 성능:
+6.93%
1개월 성능:
+6.13%
6개월 성능:
+28.03%
1년 성능:
+42.75%
1일 변동 폭
$2.835
$2.979
1주일 범위:
$2.6012
$2.979
52주 변동 폭
$1.46
$3.26
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
명칭
Xeris Biopharma Holdings Inc
전화
844-445-5704
주소
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-21 | 개시 | Jefferies | Buy |
| 2022-04-28 | 개시 | Craig Hallum | Buy |
| 2021-11-17 | 개시 | SVB Leerink | Outperform |
| 2021-10-29 | 개시 | H.C. Wainwright | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-02-18 | 개시 | Piper Sandler | Overweight |
| 2018-07-16 | 개시 | Jefferies | Buy |
| 2018-07-16 | 개시 | Leerink Partners | Outperform |
| 2018-07-16 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
Principal Financial Group Inc. Sells 10,992 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc [XERS] stock for 10,147 USD was bought by Schmid John P. - Knox Daily
Xeris Biopharma Holdings Inc [XERS] Revenue clocked in at $181.41 million, up 21.70% YTD: What’s Next? - The DBT News
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43% - Yahoo Finance
XERS: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Healthy Upside Potential: Xeris Biopharma Holdings Inc (XERS) - SETE News
The Potential Rise in the Price of Xeris Biopharma Holdings Inc (XERS) following insiders activity - Knox Daily
Xeris Biopharma Holdings Inc (XERS) requires closer examination - US Post News
Trading Day Review: Xeris Biopharma Holdings Inc (XERS) Gains Momentum, Closing at 2.67 - The Dwinnex
Allspring Global Investments Holdings LLC Boosts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Could Be Riskier Than It Looks - Simply Wall St
Taking a look at what insiders are doing to gauge the Xeris Biopharma Holdings Inc (XERS)’s direction - Knox Daily
Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
A History of Outperforming Analyst Forecasts and Beating the Odds: Xeris Biopharma Holdings Inc (XERS) - SETE News
Examining Xeris Biopharma Holdings Inc (XERS) stock is warranted - US Post News
Xeris Biopharma Holdings Inc [XERS] Records 200-Day SMA of $2.27 - Knox Daily
Xeris Biopharma Holdings Inc (XERS) shows promising results - US Post News
Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - Knox Daily
Trading Day Triumph: Xeris Biopharma Holdings Inc (XERS) Ends at 2.88, a 2.86 Surge/Plunge - The Dwinnex
The time has not yet come to remove your chips from the table: Xeris Biopharma Holdings Inc (XERS) - SETE News
This Data Shows Just How Strong Xeris Biopharma Holdings Inc (NASDAQ: XERS) Stock Is - Stocks Register
Xeris Biopharma Holdings Inc’s Shares Reel: 48.97% Quarterly Revenue Decline Amid 432.84M Market Cap - The InvestChronicle
Xeris Biopharma Holdings Inc [XERS] Records 50-Day SMA of $2.35 - Knox Daily
Xeris Biopharma Holdings Inc (XERS) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Xeris to Participate in Upcoming Investor Conferences - StockTitan
Xeris to Participate in Upcoming Investor Conferences - Business Wire
Gaining Ground: Xeris Biopharma Holdings Inc (XERS) Closes Lower at 2.70, Down -0.74 - The Dwinnex
How should investors view Xeris Biopharma Holdings Inc (XERS)? - US Post News
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by California State Teachers Retirement System - Defense World
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying - MSN
Investing in Xeris Biopharma Holdings Inc (XERS): What You Must Know - Knoxdaily.com
XERS (Xeris Biopharma Holdings) EPS (Basic) : $-0.42 (TTM As of Jun. 2024) - GuruFocus.com
A new trading data show Xeris Biopharma Holdings Inc (XERS) is showing positive returns. - SETE News
Xeris Biopharma Holdings (FRA:2B30) Cash-to-Debt : 0.29 (As of Jun. 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) Long-Term Debt & Capita - GuruFocus.com
Xeris Biopharma (NASDAQ:XERS) Rating Reiterated by HC Wainwright - Defense World
Price T Rowe Associates Inc. MD Boosts Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings (FRA:2B30) Momentum Rank : 1 (As of Aug. 16, 2024) - GuruFocus.com
Brokers Offer Predictions for Xeris Biopharma Holdings, Inc.’s Q3 2024 Earnings (NASDAQ:XERS) - Defense World
Q3 2024 EPS Estimates for Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Decreased by Analyst - MarketBeat
Insider Buying: Schmid John P., Xeris Biopharma Holdings Inc [XERS] Director invested 4,515 shares - Knox Daily
Xeris Biopharma Holdings (FRA:2B30) Enterprise Value : €553.2 Mil (As of Sep. 03, 2024) - GuruFocus.com
Xeris Biopharma Holdings (FRA:2B30) PS Ratio : 1.91 (As of Aug. 16, 2024) - GuruFocus.com
HC Wainwright Reaffirms "Buy" Rating for Xeris Biopharma (NASDAQ:XERS) - MarketBeat
Equities Analysts Offer Predictions for Xeris Biopharma Holdings, Inc.'s FY2027 Earnings (NASDAQ:XERS) - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) to Post FY2027 Earnings of $0.27 Per Share, HC Wainwright Forecasts - Defense World
XERS (Xeris Biopharma Holdings) GF Value : $3.40 (As of Aug. 15, 2024) - GuruFocus.com
XERSXeris Biopharma Holdings, Inc. Latest Stock News & Market Updates - StockTitan
XERS: A Tale of Ups & Downs – -13.90% loss in 6 Months, 2.42% in 30 Days - The InvestChronicle
Xeris Biopharma director buys $10.1k in company shares - Investing.com India
Xeris Biopharma director buys $10.1k in company shares By Investing.com - Investing.com Australia
Xeris Biopharma Holdings Inc (XERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Xeris Biopharma Holdings Inc 주식 (XERS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schmid John P. | Director |
Aug 09 '24 |
Buy |
2.37 |
4,285 |
10,134 |
20,685 |
| Schmid John P. | Director |
May 10 '24 |
Buy |
1.91 |
5,400 |
10,314 |
16,400 |
| JOHNSON JOHN | Director |
Mar 18 '24 |
Option Exercise |
1.99 |
215,600 |
429,044 |
751,412 |
| Schmid John P. | Director |
Mar 14 '24 |
Buy |
2.16 |
4,500 |
9,720 |
11,000 |
| SHERMAN JEFFREY W | Director |
Nov 27 '23 |
Buy |
1.87 |
5,400 |
10,098 |
5,400 |
| HALKUFF DAWN | Director |
Nov 20 '23 |
Buy |
1.84 |
5,410 |
9,954 |
5,410 |
| Pieper Steven | See Remarks |
Nov 20 '23 |
Buy |
1.95 |
28,000 |
54,600 |
1,176,912 |
| Schmid John P. | Director |
Nov 16 '23 |
Buy |
1.51 |
6,500 |
9,815 |
6,500 |
| Shannon John Patrick Jr | See Remarks |
Nov 17 '23 |
Buy |
1.64 |
30,769 |
50,400 |
1,408,575 |
| PERSKY MARLA | Director |
Nov 14 '23 |
Buy |
1.58 |
6,370 |
10,058 |
6,370 |
1.28%
1.94%
자본화:
|
볼륨(24시간):